Search results
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 1 day agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 23 hours ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for < ...
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 6 days agoThe paper-based KeepSight Journal from the International Macular and Retinal Foundation, Genentech's...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 1 day agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
EyePoint Pharmaceuticals stock target cut, retains Buy rating By Investing.com
Investing.com· 13 hours agoThe reduction follows a significant 43% drop in EyePoint's share value on Monday, which contrasted...
EyePoint tumbles 30% premarket on failed Phase 2 study (NASDAQ:EYPT)
Seeking Alpha· 1 day agoEyePoint (EYPT) stock tumbled nearly 30% in premarket trading Monday after the company said a Phase...
EyePoint reports mixed results in diabetic retinopathy trial By Investing.com
Investing.com· 1 day agoEyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) announced interim results from its Phase 2...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Ocular...
Benzinga· 7 days agoTherapeutix, Inc. OCUL "Ocular", the "Company"))), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative ...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 5 days agoIn August 2023, the FDA approved Eylea HD (higher dose of Eylea) for the treatment of patients with ...
Head to Head Survey: Cognition Therapeutics (NASDAQ:CGTX) vs. Opthea (NASDAQ:OPT)
ETF DAILY NEWS· 3 days agoCognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Opthea (NASDAQ:OPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...